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Thezebraﬁsh(Daniorerio)hasbecomeanattractivemodelforhumandiseasemodelingastherearealargenumberoforthologous
genes that encode similar proteins to those found in humans. The number of tools available to manipulate the zebraﬁsh genome
is limited and many currently used techniques are only eﬀective during early development (such as morpholino-based antisense
technology) or it is phenotypically driven and does not oﬀer targeted gene knockdown (such as chemical mutagenesis). The use of
RNAinterferencehasbeenmetwithcontroversyasoﬀ-targeteﬀectscanmakeinterpretingphenotypicoutcomesdiﬃcult;however,
this has been resolved by creating zebraﬁsh lines that contain stably integrated miRNA constructs that target the desired gene of
interest. In this study, we show that a commercially available miRNA vector system with a mouse-derived miRNA backbone is
functional in zebraﬁsh and is eﬀective in causing eGFP knockdown in a transient in vivo eGFP sensor assay system. We chose to
apply this system to the knockdown of transcripts that are implicated in the human cardiac disorder, Long QT syndrome.
1.Introduction
The zebraﬁsh has become an attractive model for human
disease modeling as there are a large number of orthologous
genes in the zebraﬁsh genome [1], and the encoded proteins
exhibit similar functions to those expressed in humans. The
methods that are available to manipulate zebraﬁsh gene
expression are limited, but principal among these methods
is morpholino-based antisense technology that enables tran-
sient downregulation in order to study the eﬀects of reduced
gene expression during early vertebrate development. To
create stable mutant ﬁsh lines, chemical mutagenesis (ENU)
is the method of choice; however, this forward genetics
approach is driven by phenotypic outcomes and is not able
to target and knock down speciﬁc genes. In contrast, zinc
ﬁnger nucleases (ZFNs) are an emerging technology that has
proved successful in targeted gene knockdown in zebraﬁsh
[2–4]. Unfortunately, the design and production process is
arduous and requires specialised knowledge, thus restricting
its use in the wider research community. ZFNs also do not
oﬀer the option of causing gene knockdown in a tissue-
speciﬁcmannerorofprovidingconditionalgeneknockdown
(the ability to turn on or oﬀ gene knockdown). This latter
outcome would provide a more subtle disease model that
is suited for studying late onset disorders, and it is in this
context that RNA interference may oﬀer a way forward.
The use of RNA interference (RNAi) technology has
proven to be a very useful tool in disease modelling in
mammalian systems [5]. The use of diﬀerent promoters has
allowed for tissue-speciﬁc expression of miRNAs, therefore
restricting gene knockdown to targeted areas/organs, and
also conditional knockdown with the use of Tet-on promot-
ers (the Cre/loxP system is used in mice) [6]. In brief, small
noncoding RNAs enable ﬁne-tuning gene expression at the
posttranscriptionallevelduringdevelopment,apoptosis,and
metabolism [7, 8]. These noncoding RNAs cause cleavage/
degradation, or the stalling of translation, of a target mRNA2 Journal of Biomedicine and Biotechnology
(refer to [7] for a detailed review) and can be synthetically
created to cause gene knockdown. miRNAs can be expressed
by a DNA-based vector system in which miRNA tran-
scripts,consistingofadouble-strandedhairpinstructure,are
processed by several endonucleases to form 22 nucleotide
mature miRNAs, which then form a complex with the RNA-
induced silencing complex (RISC) to carry out targeted gene
silencing.
The use of RNAi in zebraﬁsh has been controversial as
there are varying opinions regarding its eﬀectiveness, and
speciﬁcity, in causing gene knockdown. It has been suggested
that the expression of miRNAs in zebraﬁsh embryos leads to
oﬀ-target/toxic phenotypes due to ﬂooding the endogenous
miRNA pathway [9, 10]. However, transgenic zebraﬁsh lines
have been constructed that express miRNAs designed to
target desired genes of interest with no apparent toxic eﬀects.
Dong et al. and Ho et al. successfully used miRNAs to
mediate gene knockdown in zebraﬁsh and have created a
conditional knockdown model [11] and a heritable gene
knockdown ﬁsh line [12].
Given the above background, we have considered that
RNAi-based technology might allow the development of
zebraﬁsh models of heritable cardiac disorders such as Long
QT syndrome (LQTS). This syndrome is a congenital cardiac
disorder, which is characterized by a prolonged QT-interval
that can lead to fatal arrhythmias. Of the many genes
(encoding for cardiac ion channels/scaﬀolding proteins)
implicated in LQTS, we have focussed on the KCNH2 gene,
which encodes for the α-subunit of the rapid delayed inward
rectiﬁer potassium channel and is vital for the repolarisation
phaseinthecardiaccycle.Thedominantmutationsthathave
been detected in LQTS type 2 patients encompass nonsense
mutations, as well as exon deletions and duplications, which
suggest that haploinsuﬃciency of KCNH2 plays a role in the
manifestation of disease [13, 14].
Two KCNH2-type genes have been identiﬁed in zebra-
ﬁsh, termed zerg-2 and zerg-3 [1, 2]. The former appears
to be an orthologue of the human KCNH2 gene, while the
latter appears to encode a protein with KCNH2 function
but is an orthologue of the human KCNH6 gene, which is
another potassium channel that belongs to the same family
as KCNH2. Critically, the (unregulated) knockdown of both
zebraﬁsh genes leads to a cardiac phenotype (bradycardia,
atrioventricular block, and prolonged QT interval) that
mimics the phenotype seen in patients with LQTS [1, 3].
Here, we show that a commercially available miRNA vector
system is capable of mediating gene knockdown in zebraﬁsh.
We evaluate this approach in a transient in vivo method that
targets various regions of the zebraﬁsh zerg-2 and zerg-3 gene
transcripts as a prelude to mimicking the haploinsuﬃciency
ofzerg-2andzerg-3inzebraﬁshinastabletransgenicﬁshline
and to ensure that the custom-designed miRNAs are able to
cause the knockdown of their intended targets.
2.MaterialsandMethods
2.1. Zebraﬁsh Husbandry. Wild-type zebraﬁsh (Danio rerio)
were bred and maintained as described by Tang et al. [15].
2.2. Creation of pcDNA 6.2 GW/DsRed Express-miR. Lin-
earised pcDNA 6.2 GW/EmGFP-miR was recircularised by
the insertion of synthesised double-stranded oligonucleot-
ides (dsOligo) containing the same cohesive ends as the
miRNA cloning site. Two BsmBI restriction enzyme sites
were included at both 5  and 3  ends. Single-stranded DNAs
(ssOligos) were synthesised (Invitrogen) and annealed and
cloned into the pcDNA 6.2 GW/EmGFP-miR vector as
described below. The DsRed Express coding region was
ampliﬁed by PCR from the pTRE-Tight-BI-DsRed Express
vector (Clontech). The EmGFP coding region was removed
from the pcDNA 6.2 GW/EmGFP-miR vector by DraI
restriction enzyme digestion, treated with calf intestinal
phosphatise, and puriﬁed. The ampliﬁed DsRed Express
codingregionwasclonedintothepcDNA6.2GWvectorand
bidirectionally sequenced to conﬁrm the correct orientation
of DsRed Express.
2.3. miRNA Design and Construction. m i R N At a r g e ts i t e s
were designed using the BLOCK-iT RNAi Designer (Invit-
rogen) under the miR RNAi design option. The entire zerg-
2 (Genbank ID: HM209079) and zerg3 (Ensembl ID: ENS-
DARP00000085242) gene transcript sequences were used for
thedesignprocess,andtargetswerechosenbasedonlocation
(close to or within the 3  UTR) and the score the designer
programme gave to each target site. The top and bottom
ssOligos (Table 1) of the mature miRNA were synthesised
(Invitrogen) and cloned into the pcDNA 6.2-GW/dsRed-
miR expression vector according to the manufacturer’s
instructions.
2.4. Construction of eGFP Sensor Vector. As the pCS2+ vector
does not contain an eGFP reporter gene, one had to be
inserted into the vector before the eGFP sensor vector could
be used. The Kozak sequence and the eGFP coding region
was excised from pT2AL200R150G (a gift from Dr Koichi
Kawakami, National Institute of Genetics) using BamHI and
ClaI restriction enzymes. The pCS2+ vector was restriction
enzyme digested with BamHI and ClaI and the eGFP coding
region was cloned into the linearised vector (Figure 1).
The 22 nucleotides that form the mature miRNA
(Table 1) were used as the target site and the top and bottom
ssOligos were synthesized (Invitrogen). The ssOligos were
annealed according to the manufacturer’s instructions for
the construction of the miRNA vectors, and this was ligated
downstream of the eGFP reporter gene in the pCS2+ eGFP
vector. The pCS2+ eGFP vector was linearized with XhoIa n d
XbaI to create sites for ligation.
2.5. Microinjection of Zebraﬁsh and In Vivo Assay. Both miR
RNAi and the target vectors were linearised using EagIa n d
XhoI( m i R N Av e c t o r )a n dBssHII (eGFP sensor vector).
The digested products were gel-puriﬁed using MinElute Gel
Extraction Kit (Qiagen). In vitro transcription was carried
out using the mMESSAGE mMACHINE kit (Ambion, Inc),
and transcribed mRNAs were puriﬁed using the LiCl precip-
itation method (according to manufacturer’s instructions).
RNA quality was determined by gel electrophoresis andJournal of Biomedicine and Biotechnology 3
Table 1: Sequences of miRNAs and their respective targets.
Name of miRNA Target exon miRNA sequence
zerg2 miRNA 1 (top) 9 TGCTGAACCCTTGAAAGCTTTACAGCGTTTTGGCCACTGACTGACGCT
GTAAATTTCAAGGGTT
zerg2 miRNA 1 (bottom) 9 CCTGAACCCTTGAAATTTACAGCGTCAGTCAGTGGCCAAAACGCTGT
AAAGCTTTCAAGGGTTC
zerg2 miRNA 2 (top) 14 TGCTGTTCTGTAGGAGACGTCACTGAGTTTTGGCCACTGACTGACTCA
GTGACCTCCTACAGAA
zerg2 miRNA 2 (bottom) 14 CCTGTTCTGTAGGAGGTCACTGAGTCAGTCAGTGGCCAAAACTCAGT
GACGTCTCCTACAGAAC
zerg3 miRNA 1 (top) 8 TGCTGATCAGAGAGCCAATAAGCATGGTTTTGGCCACTGACTGACCA
TGCTTAGGCTCTCTGAT
zerg3 miRNA 1 (bottom) 8 CCTGATCAGAGAGCCTAAGCATGGTCAGTCAGTGGCCAAAACCATGC
TTATTGGCTCTCTGATC
zerg3 miRNA 2 (top) 15 TGCTGTGGACAGAGAGTCTGGAGACTGTTTTGGCCACTGACTGACAG
TCTCCACTCTCTGTCCA
zerg3 miRNA 2 (bottom) 15 CCTGTGGACAGAGAGTGGAGACTGTCAGTCAGTGGCCAAAACAGTCT
CCAGACTCTCTGTCCAC
zerg2 miRNA 1 target
(top) 9 TCGAGGCTGTAAAGCTTTCAAGGGTTcT
zerg2 miRNA 1 target
(bottom) 9 CTAGAgAACCCTTGAAAGCTTTACAGCc
zerg2 miRNA 2 target
(top) 14 TCGAGTCAGTGACGTCTCCTACAGAAcT
zerg2 miRNA 2 target
(bottom) 14 CTAGAgTTCTGTAGGAGACGTCACTGAc
zerg3 miRNA 1 target
(top) 8 TCGAGCATGCTTATTGGCTCTCTGATcT
zerg3 miRNA 1 target
(bottom) 8 CTAGAgATCAGAGAGCCAATAAGCATGc
zerg3 miRNA 2 target
(top) 15 TCGAGACCAGGATGACGGCTGATATAcT
zerg3 miRNA 2 target
(bottom) 15 CTAGAgTATATCAGCCGTCATCCTGGTc
quantiﬁed using a Nanodrop ND-1000 spectrophotometer
(NanoDrop Technologies, Inc).
1nL of solution containing 300pg of miRNA and 50pg
of eGFP sensor mRNA was microinjected into 1-2-cell
stage embryos (or 300pg of scrambled sequence miRNA,
which was designed not to target any known zebraﬁsh
transcript,with50pgofeGPFsensormRNA).24hourspost-
fertilization (hpf) embryos were observed and imaged using
the Zeiss Axiovert S100 microscope. All images were taken
from Nikon Eclipse Ti inverted microscope. To quantify the
raw ﬂuorescence output, each group of embryos were loaded
into a 96-well optical bottom plates in triplicate and the
ﬂuorescence was quantiﬁed using an EnVision Multilabel
Microplate Reader (PerkinElmer, Inc). The settings were as
follows: 485nm excitation ﬁlter and 535nm emission ﬁlter
with a constant incubation temperature of 28◦C. The raw
ﬂuorescence was averaged and the diﬀerence in ﬂuorescence
was compared to determine the eﬃciency of each miRNA.
2.6. Data Analysis. Fluorescence readings were expressed in
arbitrary ﬂuorescence units. Wells with only E3 medium
were used as a measure of background ﬂuorescence. The
mean background ﬂuorescence was subtracted from the
meanoftheembryocontainingwells.Thereadingswerethen
normalized against the negative control embryos and ex-
pressed as a percentage. The normalized ﬂuorescence per-
centages were analysed using one-way ANOVA.
3. Results and Discussion
3.1. miRNA Design. The mechanism behind miRNA-
mediated gene knockdown is still widely discussed (mech-
anisms ranging from translation stalling to mRNA cleavage),
so it was considered prudent to design several miRNAs that
targeted diﬀerent regions in the two genes of interest. To
mediate gene-speciﬁc knockdown in zebraﬁsh, four diﬀerent
miRNAs were designed against each of the two zebraﬁsh
kcnh2 genes (zerg-2 and zerg-3). Each target site had a
ﬁve-star ranking based on the ranking system using the
Invitrogen Block-iT RNAi Designer, which ensured that
the designed miRNAs would form the most eﬀective RNAi
molecules. At least one of the miRNA targets was located
within the 3  untranslated region (3  UTR), while the others
were located at various locations in the open reading frame4 Journal of Biomedicine and Biotechnology
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Figure 1: miRNA constructs and their eﬀects in zebraﬁsh embryos. (a) Schematic of the miRNA and the eGFP sensor vectors showing the
miRNA target sites as well as the qRT-PCR primer locations. The miRNA vector contains a CMV promoter for ubiquitous expression in all
tissues, and a DsRed Express reporter gene and the pre-miRNAs. The pre-miRNAs can be single (only one miRNA) or chained (containing
more than one miRNA under the same promoter). The eGPF sensor miRNA also contains a CMV promoter, an eGFP reporter gene, and
the mature miRNA target at the 3  UTR of the eGFP gene. The miRNA target sites for zerg-2 are located in exons 9 (miRNA 1), 14 no. 1
(miRNA 2), 14 no. 2 (miRNA 3), and 3  UTR (miRNA 4). The miRNA targets for zerg-3 are located in exon 8 (miRNA 1), exon 15 (miRNA
2), and two targets located on the 3  UTR. (b) The injection of eGFP sensor mRNA alone produces embryos that exhibit green ﬂuorescence
only, and embryos injected with both eGFP sensor and miRNA mRNA exhibit both green and red ﬂuorescence. (c) An example of embryos
injected with either miRNA with eGFP sensor or scrambled miRNA (negative control) with eGFP sensor. The ∗ indicates the presence of
the midbrain hindbrain boundary.Journal of Biomedicine and Biotechnology 5



















































































































Figure 2: In vivo eGFP sensor assay for zerg-2 miRNAs. (a) zerg-2 miRNA 1 with eGFP knockdown at approximately 69%. (b) zerg-2
miRNA 2 with eGFP knockdown at approximately 73%. (c) zerg-2 miRNA 3 with eGFP knockdown at approximately 32% (the results are
not statically signiﬁcant). (d) zerg-2 miRNA 4 with eGFP knockdown at approximately 88%.
∗∗P < 0.01. All statistical analysis was carried
out using one-way ANOVA. The percentage of ﬂuorescence emitted by the injected embryos was determined by comparison to negative
control embryos (those injected with scrambled miRNA).
(ORF; Figure 1(a)). Dong et al. have shown that miRNA
targetsiteslocatedatthe3  UTR are more eﬀectiveatcausing
gene knockdown compared to miRNA sites in the middle
of an ORF [12], and our own laboratory has shown that it
is also the case with the Block-iT system (data not shown).
It has been suggested that this bias in eﬃciency is due to
the translational machinery displacing bound miRNAs in
the ORF regions as the machinery moves from the cap-
binding complex to the ORF [7, 16]. Despite this, it has also
been found that many miRNA target sites are found within
ORFs [7]. Therefore, it was thought that gene expression
knockdown could be maximized by targeting four diﬀerent
locations within each transcript.
3.2. Transient In Vivo Testing of the Eﬃcacy of Individual
miRNAs. The use of miRNA in mediating gene knockdown
in zebraﬁsh has been successfully achieved by Dong et al.
and Ho et al. [11, 12]. The miRNA backbone used by
Dong et al. was an endogenous zebraﬁsh miRNA that is an
orthologue of the mammalian miR-30e [12]. Here we have
usedacommerciallyavailablemiRNAbackbonethatisbased
on the endogenous mouse miR-155, which has previously
been shown to be eﬀective in causing gene knockdown in
mammalian cell lines [17]. Despite the fact that Dong et al.
[12] found the eﬃciency of the zebraﬁsh orthologue of miR-
155 to be less than miR-30e, the data did not suggest that the
mouse miR-155 backbone would not be eﬀective in causing
gene knockdown in zebraﬁsh.
It was decided to validate the Block-iT miRNA system
in the zebraﬁsh and also to test the eﬀectiveness of the
custom-designed miRNAs by using a transient in vivo sensor
assay. If the custom-designed miRNAs eﬀectively caused
knockdown in the transient in vivo sensor assay, then the
miRNAs could be stably incorporated into the zebraﬁsh
genome to create transgenic ﬁsh lines. The transient in vivo
sensor assay involved cloning the putative miRNA target
sites into the 3  UTR of a reporter/sensor gene [9, 18, 19]
(Figure 1(a)). Each miRNA target was inserted downstream
of an eGFP reporter gene (eGFP sensor), and both the
miRNA and their respective sensor were coinjected into6 Journal of Biomedicine and Biotechnology
























































































































Figure 3: In vivo eGFP sensor assay for zerg-3 miRNAs. (a) zerg-3 miRNA 1 with eGFP knockdown at approximately 90%. (b) zerg-3
miRNA 2 with eGFP knockdown at approximately 45% (the results are not statically signiﬁcant). (c) zerg-3 miRNA 3 with eGFP knockdown
at approximately 98%. (d) zer-g3 miRNA 4 with eGFP knockdown at approximately 77%.
∗∗P < 0.01;
∗∗∗P < 0.001. All statistical analysis
was carried out using one-way ANOVA. The percentage of ﬂuorescence emitted by the injected embryos was determined by comparison to
negative control embryos (those injected with scrambled miRNA).
one-cell stage embryos. The duration of this assay was
restricted by the half-life of the capped miRNA transcripts,
and the embryos were screened for eGFP expression at
24 hours post-fertilization (hpf). At this stage, eGFP and
DsRed expression could be detected and the eﬀect of the
miRNAs assessed. In the event of targeted knockdown, eGFP
ﬂuorescence would be expected to decrease (Figure 1(b)).
As the miRNA target site was linked to eGFP, the emGFP
reporter gene in the Block-iT expression vector was replaced
with the DsRed Express reporter gene. The assessment of
the assay was based solely on the level of eGFP expression
produced by the injected embryos, and any phenotypic
outcomes (i.e., heart rate, electrocardiogram) were not
scored.
All eight miRNAs were able to decrease eGFP expression
(Figures 2 and 3). Zerg-2 miRNA 4 caused the greatest level
of eGFP expression knockdown (approximately 88%) with
zerg-2 miRNA 1 and 2 causing approximately 69–73% eGFP
knockdown (Figure 2). Zerg-2 miRNA 3 was only able to
cause 32% knockdown (Figure 2). Zerg3 miRNA 3 caused
the greatest level of eGFP knockdown (approximately 98%)
with zerg3 miRNA 1 and 4 causing approximately 77–90%
knockdown (Figure 3); the extent of knockdown caused by
Zerg-3 miRNA 2 was not statistically signiﬁcant. The results
from the in vivo sensor assay demonstrate that the Block-iT
miRNA backbone is functional in zebraﬁsh and the custom-
designed miRNA is capable of causing gene knockdown as
assessed by the in vivo sensor system.
3.3. Assessment of Oﬀ-Target Eﬀects. One of the main issues
in using RNAi knockdown technology is the possibility of
causing oﬀ-target gene knockdown. In zebraﬁsh, this has
proven to be one of the main downfalls of using RNAi as it
hasbeenfoundthatthemiRNAisvitalforearlydevelopment
and the introduction of exogenous miRNA might cause
competition for miRNA processing machinery [9, 10]. This
in turn leads to a decrease in endogenous miRNA which
is needed to clear maternal mRNA during development.
Zhao et al. have reported phenotypes that are associated
with toxic eﬀects from the use of RNAi in zebraﬁsh, whichJournal of Biomedicine and Biotechnology 7
included the loss of the midbrain-hindbrain boundary in
siRNA-injected embryos [10]. In the current study there
has been no evidence of the loss of the midbrain-hindbrain
boundary;however,itcannotberuledoutthatthereistissue-
speciﬁc toxicity that is not readily apparent (Figure 1(c)).
4. Conclusions
The transient in vivo eGFP sensor assay has shown that the
Block-iT is functional in the zebraﬁsh system and also that
the designed miRNAs are capable of causing knockdown
at the protein level. These pilot data lay the foundation
for constructing transgenic zebraﬁsh expressing the miRNAs
u s e dh e r ei no r d e rt om o d e lL Q T S .
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